secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0001437749-23-021752
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs 1Q24 revenue $50.6M (+0.4%), net loss $(0.10)/share, AOI up 46% to $9.5M
--------------------------------------------------------------------------------

- Revenue $50.6M, +0.4% YoY; core organic growth 2.0% (ex-currency/COVID).
- Operating loss narrowed 85.5% to $(0.7M); net loss $(0.5M) or $(0.10)/share.
- Non-GAAP AOI excluding unusual items rose 46.2% to $9.5M (18.8% of revenue).
- Divisions: Calibration +12.5% core organic, Sterilization +7.2%, Clinical Genomics -4.4%, Biopharma -6.6%.
- Headwinds: slowing capital equipment, Sema4 loss, currency; cost cuts aiding profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000143774923021752/0001437749-23-021752-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000143774923021752/mlab20230802_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-021752

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer